All the top Biotech & Pharma news in one daily newsletter.

Want to understand how these updates are formatted? Check-out the FAQ.

Have any feedback? I’d love to hear you from - connect with me on LinkedIn. 📣

THE GOOD
Approvals & Labels

Gilead's Yeytuo (lenacapavir), HIV capsid inhibitor, gains European Commission approval for twice-yearly PrEP injection
Small molecule, infectious disease, HIV, PrEP, capsid inhibitor, preventive medicine - Read more

THE GOOD
Business Development & Partnerships

Fosun grants Sitala Bio ex-China rights to inflammatory disease drug for $670M deal, including $25M upfront
Licensing deal, inflammatory disease, small molecule, milestone payments, equity investment - Read more

Novartis, BioArctic partner on neurodegeneration drug using BrainTransporter technology; $30M upfront, potential $772M deal
Research collaboration, neurological, drug delivery technology, milestone payments, licensing deal - Read more

Lineage Cell Therapeutics, Demant partner on hearing loss cell therapy; $12M research collaboration announced
Research collaboration, hearing loss, cell therapy, preclinical development, milestone payments - Read more

Osivax receives $19.5M from BARDA to develop universal pandemic flu vaccine using nanoparticle technology
Government funding, vaccine, infectious disease, manufacturing, nanoparticle technology - Read more [Paywall]

Immuron partners with InvestorHub to enhance investor engagement through interactive platform
Investor relations, digital health, corporate communications - Read more

PRESENTED BY YOU?
Get the attention of 2000+ Biotech & Pharma Professionals 🤩

Do you offer a biotech/pharma-focused product or service?

Or looking to get investor/analyst interest on your budding start-up?

Considering sponsoring TLDR Biotech to get in-front of an engaged audience of biotech & pharma-focused professionals.

Just reply to this email* or message me on LinkedIn to learn more.

*If you’re reading this on the web version, email [email protected]

✅ More Good News ✅

THE GOOD
Clinical Trials

Regeneron's siRNA drug cemdisiran achieves Ph3 primary endpoint in generalized myasthenia gravis, FDA filing planned
Small molecule, neurological, siRNA therapy, myasthenia gravis, C5 inhibition, autoimmune - Read more

Akeso, Summit's ivonescimab PD-1xVEGF therapy meets Ph3 overall survival endpoint in non-small cell lung cancer
Antibody, cancer, bispecific antibody, non-small cell lung cancer, PD-1 inhibitor, VEGF inhibitor - Read more

Lilly's Ph3 orforglipron GLP-1 pill shows 10.5% weight loss in type II diabetes; FDA submission planned
Small molecule, metabolic, GLP-1 agonist, type II diabetes, obesity, oral therapy - Read more

THE GOOD
Fundraises

Therna Biosciences raises $10M seed funding for AI-powered programmable RNA medicines
RNA therapeutics, AI/ML platform, platform technology, drug discovery, programmable molecules - Read more

Legend Innovation commits $50M investment in Mid-Atlantic BioTherapeutics for anti-aging therapies development
Neurological, anti-aging, clinical-stage, oncology, AI-driven, infectious disease - Read more

Baxiva raises $3M CARB-X funding, advancing E. coli vaccine platform from ETH Zurich
Infectious disease, vaccine, platform technology, antibacterial, preclinical, E. coli - Read more

Leal Therapeutics raises $30M Series A for schizophrenia and ALS clinical trials
Neurological, schizophrenia, ALS, clinical-stage, small molecule - Read more [Paywall]

Hemogenyx raises £570K ($767K) funding for Phase I trials of leukemia CAR-T therapy
Oncology, cell therapy, clinical-stage, leukemia, CAR-T - Read more

THE GOOD
Investments

ChemPartner to open 12,000-square-foot Boston research facility offering preclinical services on September 10
Contract research organization, preclinical services, strategic expansion, operational - Read more

Nusano opens Salt Lake City radioisotope plant to combat supply shortages for cancer diagnostics and therapeutics
Radiopharmaceutical, oncology, manufacturing, supply chain, operational - Read more

Bayer invests $43M to upgrade Veracruz API facility, part of broader $160M Mexico expansion
API manufacturing, hormone products, operational, manufacturing expansion, strategic investment - Read more

THE BAD
Layoffs

Pfizer cuts 100 workers at former Seagen HQ amid post-acquisition cost-saving efforts
Antibody-drug conjugate, oncology, operational, cost reduction, workforce reduction - Read more

THE BAD
Regulatory

NCI ends funding for pediatric brain tumor consortium, redirects support to broader children's oncology group network
Pediatric oncology, brain cancer, government funding, clinical trials, strategic - Read more

THE UGLY
Politics & Policy

Trump and Kennedy reportedly considering ban on COVID-19 vaccines in US, escalating anti-vaccine policies
mRNA vaccine, infectious disease, regulatory, policy change - Read more

CDC appoints vaccine critic Retsef Levi to lead COVID-19 workgroup reviewing vaccine safety data
mRNA vaccine, infectious disease, regulatory, strategic, operational - Read more

You’re all caught up on the latest Pharma & Biotech News!

TLDR Biotech wants to hear from you! 📣

Have comments/questions/complaints about this newsletter?
Send me an email - I want your brutally honest feedback. 📝

If you find the content useful and think a colleague would too, please share TLDR Biotech with them! ♻️

And lastly - connect with me on LinkedIn!

Disclaimer: Content, news, research, tools, and mention of stock or tradeable securities are for educational and illustrative purposes only and do not imply a recommendation or solicitation to buy or sell a particular security or to engage in any particular investment strategy. Read the full terms & conditions here